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Abstract
The cholinergic system is known to be necessary for normal attentional processing. However, the receptors and mechanisms mediating the effects of
acetylcholine on attention remain unclear. Previous work in our laboratory suggested that cholinergic muscarinic receptors are critical for maintaining
performance in an attention-demanding task in rats. We examined the role of the muscarinic M1 receptor and protein kinase C (PKC), which is activated
by the M1 receptor, in attention task performance. Rats were trained in an attention-demanding task requiring discrimination of brief (500, 100, 25 ms)
visual signals from trials with no signal presentation. The effects of muscarinic M1 receptor blockade were assessed by administering dicyclomine
(0–5.0 mg/kg). The effects of PKC inhibition were assessed by administering chelerythrine chloride (0–2.0 mg/kg). Dicyclomine decreased the accuracy
of detecting longer signals in this attention task, including when attentional demands were increased by flashing a houselight throughout the session.
Chelerythrine chloride decreased the accuracy of signal detection in the standard version of the task but not when the houselight was flashed
throughout the session. The present findings indicate that muscarinic M1 receptors are critical for maintaining performance when attentional demands
are increased, and that PKC activity may contribute to some aspects of attentional performance.

Keywords
Acetylcholine, attention, basal forebrain, vigilance

Introduction
The cholinergic system is known to play a critical role in
attentional processing (Everitt and Robbins, 1997; Sarter
et al., 2005). Many experiments have examined, in tasks
designed to assess attention, the eﬀects of drugs that act at
nicotinic receptors (Mirza and Stolerman, 1998; Rezvani et al.,
2002; Turchi et al., 1995), and several experiments have begun
to investigate the critical nicotinic receptor subtypes for maintaining normal attention (Blondel et al., 2000; Grottick et al.,
2003; Hahn et al., 2003; Howe et al., 2010). Drugs that block
muscarinic receptors also disrupt attentional performance
(Mirza and Stolerman, 2000; Ruotsalainen et al., 2000) as
well as performance in other procedures that are thought to
be sensitive to changes in attentional processing, such as latent
inhibition (Barak and Weiner, 2007, 2009). In a two-lever sustained attention task requiring discrimination of signals from
trials with no signal presentation, blockade of muscarinic
receptors with scopolamine has been shown to decrease accuracy, although whether the eﬀects have been selective
decreases in accuracy of signal detection (Johnson and Burk,
2006; McQuail and Burk, 2006), selective decreases in accuracy on trials with no signal presentation (Rezvani et al., 2009)
or decreases in accuracy on both of these trial types (Bushnell
et al., 1997) has varied across experiments.

The eﬀects of blocking muscarinic receptor subtypes on
measures of sustained attention have not been tested. The
eﬀects of drugs selective for speciﬁc muscarinic receptor subtypes have been tested on measures of memory, with the
muscarinic M1 and M2 receptors being most thoroughly examined. Muscarinic M1 receptors are predominantly located
post-synaptically (Levey et al., 1991), and blockade of these
receptors generally disrupts performance in measures of learning and memory (Aura et al., 1997; Bymaster et al., 1993;
Ferreira et al., 2003; Hagan et al., 1987). Moreover, intrastriatal infusions of a selective muscarinic M1 receptor toxin
impair task switching (McCool et al., 2008). Finally, M1 receptor knockout mice show impaired responding to a previously
rewarded visual cue (Gulledge et al., 2009). Muscarinic M2
receptors are primarily located presynaptically, acting as autoreceptors to negatively modulate acetylcholine release
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(Levey et al., 1991). Muscarinic M2 receptor antagonists have
typically been associated with cognition enhancement
(Gulledge et al., 2009; Quirion et al., 1995). Thus, previously
observed attentional deﬁcits induced by muscarinic receptor
antagonists (references above) are most likely associated with
muscarinic M1 receptors.
Recent experiments have begun to examine the contributions of second messenger pathways in attention. For example, intra-prefrontal cortical infusions of a cAMP-dependent
protein kinase inhibitor disrupt accuracy in a ﬁve-choice serial
reaction time task (Paine et al., 2009). Muscarinic M1 receptors
act via the second messengers inositol triphosphate and diacylglycerol, leading to activation of protein kinase C (PKC)
(Caulﬁeld, 1993; Haas and Dokas, 1999). Chelerythrine chloride inhibits the translocation of cytosolic PKC to the membrane and therefore can be used to study the eﬀects of
decreasing PKC activity (Chao et al., 1998; Siomboing et al.,
2001). Chelerythrine chloride has been shown to impair learning acquisition and memory formation (Sacchetti and
Bielavska, 1998; Serrano et al., 1995) and to reverse memory
impairments associated with PKC overactivity, either induced
by a phorbol ester administration (Birnbaum et al., 2004) or
in aged rats (Brennan et al., 2009). There are no available
experiments in the literature that report the eﬀects of manipulating PKC activity on attentional performance. These experiments are important for beginning to determine whether
alterations in attention contribute to memory-related eﬀects
of PKC modulation.
The present experiments tested the eﬀects of muscarinic M1
receptor blockade, induced by dicyclomine administration,
and PKC inhibition, induced by chelerythrine chloride administration, on attention task performance. Rats were trained in a
two-lever attention task that required discrimination of visual
signals from trials with no signal presentation. We hypothesized that dicyclomine would decrease the accuracy of signal
detection without aﬀecting accuracy on trials with no signal
presentation, similar to the eﬀects reported following muscarinic receptor blockade with scopolamine that were previously
observed using similar conditions in our laboratory (Johnson
and Burk, 2006; McQuail and Burk, 2006). Animals were
tested in a ‘standard’ version of the task and with greater background noise to increase attentional demands. The experiment
examining the eﬀects of chelerythrine chloride on attention
was more exploratory. Our goal was to test whether chelerythrine chloride produced a selective deﬁcit in task performance,
such as a decrease in signal detection, or whether there were
less speciﬁc patterns of impairment (for example, decreased
accuracy on all trial types).

Methods and materials
Subjects
Subjects included a total of 18 male Long-Evans rats (Charles
River Laboratories Inc., Wilmington, MA, USA), weighing
151–175 g when arriving at the laboratory. Animals were
housed individually in hanging wire cages in a vivarium
with a 14/10 h light/dark cycle (lights on 0600–2000). All
behavioral testing occurred between 0900 and 1200, for ﬁve
or six days each week. Rats were given ad libitum access to
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standard rat chow, but were water restricted on testing days,
receiving water during task performance and for 30 min
following testing sessions. Rats were given overnight water
access prior to days they were not trained, to maintain the
animals’ health throughout the experiment. The experimental
protocol was approved by the Institutional Animal Care and
Use Committee at the College of William and Mary.

Apparatus
Rats were trained in one of 12 chambers (Med Associates,
Inc., Georgia, VT). Each chamber was enclosed within a
sound-attenuating box. One side of the chamber contained
two retractable levers, a water port with a dipper to deliver
water (0.01 mL) situated between the two levers, and a central
panel light located above the water port. A houselight was
located in the back of the chamber. Illumination levels for
these chambers have been previously reported (Burk, 2004).
The behavioral testing programs and data collection were
managed by a personal computer utilizing Med-PC version
IV software.

Behavioral training
Rats were trained in a sustained attention task developed by
Bushnell et al. (1994) and validated by McGaughy and Sarter
(1995). The houselight remained illuminated throughout all
training sessions. In the ﬁrst stage of training, the levers were
extended throughout the session and the dipper was raised
following each lever press. To attempt to prevent a lever
bias, following ﬁve consecutive presses on a single lever, the
other lever had to be pressed to receive water access. After
reaching a criterion of 120 lever presses per session for three
sessions, rats were trained to discriminate between signals (1 s
illumination of the panel light) and nonsignals (no illumination of the panel light). After a signal or nonsignal, the levers
were extended into the chamber. For half the animals, following a signal, a press on the left lever was considered a hit and
the dipper was raised to allow water access, while a press
on the right lever was considered incorrect, scored as a miss
and the rat received no water. After a nonsignal, a press on
the right lever was considered correct, scored as a correct
rejection and water access was given, while pressing the left
lever was scored as a false alarm and the dipper was not
raised. After a lever press or a failure to press a lever within
3 s after the levers were extended (scored as an omission) the
levers were retracted. The rules were reversed for the other
half of the rats (a right lever press was considered correct after
a signal and a left lever press was considered correct after a
nonsignal). The inter-trial interval (ITI) varied (12 6 3 s)
during training to prevent the rats from anticipating the
onset of the next trial. Incorrect responses were followed by
a correction trial that was identical to the previous trial. Three
consecutive incorrect responses triggered a forced trial where
only the correct lever was extended until the lever was pressed
or 90 s elapsed. When the three consecutive errors occurred
on signal trials, the panel light remained illuminated while the
lever was extended. Animals were trained in this task until
they reached a criterion of 70% hits and 70% correct rejections for three consecutive sessions. In the next level of
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training the signal duration was reduced and varied within
each session (500, 100, or 25 ms). A session consisted of 162
trials with an ITI of 9 6 3 s. The signal duration and ITI were
decreased to place higher demands on attentional processing
(McGaughy and Sarter, 1995; Parasuraman et al., 1987).
Animals were trained in this version of the task to a criterion
of 70% hits following the 500 ms signal and 70% correct
rejections for three consecutive sessions in order to move to
the drug administration phase of the experiment.

Preparation of dicyclomine and behavioral testing
Dicyclomine hydrochloride was dissolved in saline and
injected into the intraperitoneal cavity in a volume of
1.0 mL/kg. The doses used were 0.0, 0.625, 1.25, 2.50 and
5.0 mg/kg of dicyclomine. Typical dose ranges for dicyclomine are at least 8.0 mg/kg in experiments examining the
eﬀects of this drug on learning and memory (Fornari et al.,
2000; Soares et al., 2006). We chose a lower dose range
because, in pilot studies, we observed that 10.0 mg/kg resulted
in an almost complete failure to press a lever in the task. The
dicyclomine solution was heated for approximately 5 min
until the solution was visibly dissolved.
Rats (n ¼ 10) received ﬁve sessions with two diﬀerent task
conditions: the same task the animals had trained prior to
drug administration (the standard task) and the same task
with the houselight ﬂashed as a distracter throughout the
session (1 s on/oﬀ). The order of the task manipulations and
drug administration was randomized for each rat. Rats
received each drug dose prior to the two task conditions,
for a total of 10 injections. Animals were tested in the attention task 15 min after each injection. Between drug administration days, rats returned to the standard task and were
required to meet a criterion of 70% hits at the 500 ms signal
and 70% correct rejections before proceeding to the next drug
administration day.

Preparation of chelerythrine chloride and
behavioral testing
Chelerythrine chloride was administered (0.0, 1.0, and 2.0 mg/
kg; ip) once the rats (n ¼ 8) had reached criterion for training
in the two-lever attention task. These doses are in the range
used during chronic administration studies assessing the ability
of PKC inhibition to attenuate stress-induced memory deﬁcits
(Hains et al., 2009). Moreover, a higher dose of chelerythrine
chloride (4.0 mg/kg) substantially increased the number of
omissions during pilot studies with this attention task.
Chelerythrine chloride was suspended in a saline solution
and placed on a vortex prior to injection. Each rat was
given an injection 10 min prior to performing the two-lever
attention task. Rats were trained in the attention task for at
least 1 day between injection sessions. The order of drug
administration was randomized and animals received chelerythrine chloride prior to the standard task and the same task
with the houselight ﬂashing (1.0 s on/oﬀ) throughout the session. Between these drug administration sessions, rats were
required to reach criterion (70% hits at the 500 ms signal
and 70% correct rejections) in the standard attention task.
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Behavioral measures and statistical analyses
The number of hits (h), misses (m), correct rejections (cr),
false alarms (fa), and omissions were recorded for each testing
session. The measures of accuracy for signal trials were the
relative hits (h/(hþm)) and for nonsignal trials were the relative correct rejections (cr/(crþfa)). The relative hits were analyzed using a repeated-measures analysis of variance
(ANOVA) with the factors of task (standard and ﬂashing
houselight), signal duration and drug dose. The relative correct rejections were analyzed using a repeated-measures
ANOVA that included task and dose as factors. Omissions
were analyzed separately from measures of accuracy. All pvalues were corrected with the Huynh–Feldt procedure.
Signiﬁcant ANOVAs were further assessed by comparing
vehicle administration sessions with performance following
each drug dose, using t-tests that were corrected with the
Bonferroni procedure. A level of a ¼ 0.05 was used to determine statistical signiﬁcance.

Results
Effects of dicyclomine on attention task performance
One animal did not maintain stable performance and was not
included in any data analyses. Overall, dicyclomine administration decreased accuracy on trials with the 500- and 100-ms
signals (Figure 1). This observation was tested with a task 3
dose 3 signal duration ANOVA for the relative hits. This
analysis yielded a main eﬀect of signal duration, reﬂecting
higher levels of accuracy following longer signal durations
(F(2,16) ¼ 169.6, p < 0.05). More importantly, there was
also a signiﬁcant main eﬀect of dose (F(4,32) ¼ 3.095,
p < 0.05) and a signiﬁcant dose 3 signal duration interaction
(F(8,64) ¼ 2.936, p < 0.05). The task 3 dose 3 signal duration interaction was not signiﬁcant, thus the data were
combined from the standard and distracter sessions for subsequent analyses of the signiﬁcant dose 3 signal duration
interaction. The basis for the dose 3 signal duration interaction was assessed by conducting one-way ANOVAs that
included the factor dose for each signal duration. These
ANOVAs yielded a main eﬀect of dose for the 500-ms
(F(4,32) ¼ 3.456, p < 0.05) and 100-ms (F(4,32) ¼ 4.648,
p < 0.05) signals, but not for the 25-ms signal. For the 500ms signal, the 0.625 mg/kg, 2.5 mg/kg and 5.0 mg/kg dicyclomine doses all diﬀered signiﬁcantly compared with the vehicle
condition (all p < 0.05). For the 100-ms signal, the 2.5 mg/kg
dicyclomine dose was signiﬁcantly diﬀerent compared with
vehicle (t(8) ¼ 3.096, p < 0.05), and the diﬀerence between
vehicle and 5.0 mg/kg dicyclomine approached signiﬁcance
but was not signiﬁcant after the Bonferroni correction was
applied.
For correct rejections, there was a main eﬀect of task,
reﬂecting a decrease in accuracy on nonsignal trials when
the distracter was presented (Standard task: 0.858 6 0.015;
Distracter task: 0.790 6 0.019). However, there was no eﬀect
of dose nor was there a task 3 dose interaction for correct
rejections. For omissions, a task 3 dose ANOVA did
not yield any signiﬁcant eﬀects (Figure 1).
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Figure 1. The figure depicts relative hits (A), relative correct rejections (B) and omissions per session (C) following each dicyclomine dose (0–5.0 mg/kg).
In (A) the bars denote the different signal durations (500, 100 and 25 ms). Dicyclomine produced a significant dose 3 signal duration that did not further
interact with task (p < 0.05; n ¼ 9). Thus, the data shown here are combined from the standard and flashing houselight conditions. Compared with vehicle,
dicyclomine (0.625, 2.5 and 5.0 mg/kg) decreased the accuracy of detecting the 500-ms signal and at one dose (2.5 mg/kg) decreased the accuracy of
detecting the 100-ms signal. The asterisks denote dicyclomine doses that were significantly different compared with vehicle administration (p < 0.05).
There were no effects of dicyclomine on correct rejections or omissions.

Effects of chelerythrine chloride on attention
task performance
The data from one rat were not included in any analyses because
that animal did not maintain consistent performance levels
throughout the experiment. Chelerythrine chloride administration decreased signal detection in the standard task but did not
aﬀect performance when background noise was increased. A
task 3 dose 3 signal duration ANOVA yielded a signiﬁcant
three-way task 3 dose 3 signal duration interaction (F(4,24)
¼ 3.90, p < 0.05). To examine the basis of this interaction, we
conducted separate dose 3 signal duration ANOVAs for the
standard and distracter testing sessions. For the standard task,
the dose 3 signal duration ANOVA yielded a main eﬀect of
signal duration (F(2,14) ¼ 94.6, p < 0.05), reﬂecting decreased
relative hits during shorter signal durations, and of dose (F(2,14)
¼ 4.39, p < 0.05). Post hoc tests revealed that the relative hits following 2.0 mg/kg chelerythrine chloride were signiﬁcantly lower

compared with following vehicle administration (t(7) ¼ 2.02,
p < 0.05; Figure 2). For the distracter condition, the dose 3
signal duration ANOVA did not yield any statistically signiﬁcant
eﬀects of chelerythrine chloride on the relative hits (Figure 3).
Thus, chelerythrine chloride administration decreased signal
detection in the standard task, but the basis for the further interaction with signal duration (as part of the signiﬁcant task 3 dose
3 signal duration interaction) could not be determined. For correct rejections, there was a signiﬁcant eﬀect of task, reﬂecting
lower accuracy on nonsignal trials during the distracter
condition (Figures 2 and 3), but no main eﬀect of dose or task
3 dose interaction. There were no statistically signiﬁcant eﬀects
of task or dose on omissions.

Discussion
The present experiment was designed to test the eﬀects of
muscarinic M1 receptor blockade and PKC inhibition on

Robinson et al.

1147

Figure 2. The figure depicts relative hits (A), relative correct rejections (B) and omissions per session (C) following each chelerythrine chloride dose
(0–2.0 mg/kg) in the standard task trained prior to drug administration. In (A) the bars depict the different signal durations (500, 100 and 25 ms). The
asterisk denotes a significant decrease in the relative hits following 2.0 mg/kg chelerythrine chloride compared with vehicle administration (p < 0.05;
n ¼ 7). There were no significant effects of chelerythrine chloride on correct rejections or omissions.

attention task performance. Dicyclomine-induced muscarinic
M1 receptor blockade decreased the accuracy of signal detection (relative hits) in the standard and distracter versions of
this sustained attention task. The lack of drug eﬀects on nonsignal trial accuracy indicates that dicyclomine administration
did not disrupt the ability to respond based on the task rules.
There were no signiﬁcant eﬀects of any drug treatments on
omissions, although several of the higher drug doses produced trends for increases in omissions. The highest number
of omissions remained near an average of 20 per session,
which represents less than 13% of the total number of
trials. Thus, it seems unlikely that the drugs had large eﬀects
on motivation or on the motoric abilities necessary for the
task. Finally, dicyclomine administration decreased detection
of the longer (500- and 100-ms) signals in this sustained
attention task. On 25-ms signal trials, the rats typically
responded (incorrectly) as if a nonsignal was presented by
pressing the miss/correct rejection lever. Thus, dicyclomine
administration appears to decrease signal detection, and this
eﬀect is conﬁned to trials that are most likely to be identiﬁed
by the animal as signals. Overall, this pattern of impairment is
similar to the deﬁcits observed following widespread loss of
corticopetal cholinergic neurons (McGaughy and Sarter,

1998; McGaughy et al., 1996), suggesting that muscarinic
M1 receptors in multiple cortical regions may contribute to
attentional performance (Sarter et al., 2005). Loss of hippocampal cholinergic projections does not aﬀect accuracy in the
standard version of this attention task (Sarter et al., 2002).
Thus, the eﬀects of dicyclomine are more likely to be mediated by the cortical muscarinic M1 receptors compared with
hippocampal muscarinic M1 receptors.
Chelerythrine chloride selectively decreased signal detection accuracy in the standard version of the attention task.
Accuracy on nonsignal trials and the number of omitted trials
were unaﬀected by chelerythrine chloride administration,
suggesting this drug produced a relatively selective eﬀect on
task performance. Interestingly, a selective decrease in signal
detection in the present task is associated with pharmacological or lesion manipulations that depress the functioning of
the cholinergic system (for example, McGaughy et al., 1996).
Other manipulations, such as exposure to amphetamine,
decrease the accuracy on nonsignal trials in this task
(Kondrad and Burk, 2004). Moreover, lesions of the dorsal
noradrenergic bundle do not aﬀect performance in this twolever sustained attention task (McGaughy et al., 1997).
Thus, the selectivity of the eﬀects of chelerythrine chloride
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Figure 3. The figure depicts relative hits (A), relative correct rejections (B) and omissions per session (C) following each chelerythrine chloride dose
(0–2.0 mg/kg) in the distracter task with the houselight flashing throughout the session. In (A) the bars denote the different signal durations (500,
100 and 25 ms). Chelerythrine chloride did not differentially affect hits, correct rejections or omissions during the distracter condition (n ¼ 7).

administration suggests that it may be possible to associate
the actions of PKC on attentional processing required by the
standard task with speciﬁc neurotransmitter systems, and that
the interactions between PKC and the cholinergic system
represent a logical starting point.
Chelerythrine chloride administration did not diﬀerentially aﬀect group performance when background noise was
increased. The standard version of this task is thought to
require more bottom-up, signal-driven processing, whereas
increasing background noise is thought to activate topdown cognitive modulation in response to attentional challenge (Sarter et al., 2005). The present ﬁndings suggest that
PKC may contribute to dissociable aspects of attentional
processing, as chelerythrine chloride administration decreased
the relative hits in the standard version of the task but not
when background noise was increased. Collectively, our ﬁndings suggest that it is possible that PKC contributes to some
aspects of processing mediated by muscarinic M1 receptor,
namely, those aspects necessary for maintaining performance
in the standard task. Certainly, concurrent manipulations of
the muscarinic M1 receptor and PKC during the standard
task are needed to test this hypothesis. Previous studies
have shown correlations between ﬁring rates of prefrontal
and posterior parietal cortical neurons and presentation of
a ﬂashing houselight in this attention task (Broussard et al.,

2009; Gill et al., 2000). Moreover, lesions of cholinergic projections to these cortical regions can alter task performance
when distracters are presented, but do not aﬀect performance
in the standard task (Broussard et al., 2009; Newman and
McGaughy, 2008). Infusions of dicyclomine into these discrete cortical areas would help to identify whether muscarinic
M1 receptors in these regions contribute to the present eﬀects
observed following systemic administration.
Several caveats need to be kept in mind when interpreting the
present results. First, although the M1 receptor antagonist
dicyclomine shows a much greater aﬃnity for binding to
muscarinic M1 receptors compared with muscarinic M2 receptors (Kunysz et al., 1988), this drug has been shown to bind to M3
receptors (Doods et al., 1987), which could contribute to the
signal detection deﬁcits observed in the present experiment
following dicyclomine administration. This concern is somewhat tempered by the lower doses of dicyclomine used in the
present experiment compared with in other experiments assessing learning and memory. Second, the possibility exists that
if acetylcholine is released and the muscarinic M1 receptor is
occupied by an antagonist, then a greater amount of acetylcholine binds to the muscarinic M2 receptors, leading to decreased
acetylcholine release which would be expected to decrease signal
detection in this attention task. Thus, the locations of muscarinic
M1 and M2 receptors and their regulation of acetylcholine release
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make it diﬃcult to deﬁnitively associate the attentional deﬁcits
only with muscarinic M1 receptors. Third, the eﬀects of scopolamine on similar two-lever sustained attention tasks have not
always been consistent, with some experiments demonstrating
that muscarinic receptor blockade selectively decreases signal
detection (Johnson and Burk, 2006; McQuail and Burk, 2006)
while other experiments demonstrate that muscarinic receptor
blockade decreases accuracy on trials with no signal presentation (Rezvani et al., 2009) or on both signal and nonsignal trials
(Bushnell et al., 1997). The experiments presented in these papers
vary in deprivation and reward procedures (food or water), in
whether the signal duration or signal intensity is varied, and in
apparatus (whether there is a noise generator above one of the
choice levers). Examination of the eﬀects of dicyclomine with
these diﬀerent methodological procedures would be useful for
testing the generalizability of the eﬀects of M1 receptor blockade
observed in the present experiment. If such studies revealed that
the eﬀects of dicyclomine, similar to those of scopolamine, vary
dependent upon some experimental parameters, then it would be
important to investigate which aspects of the procedures bias the
sensitivity of the measures in this task that detect the eﬀects of
muscarinic receptor manipulations. Finally, a relatively narrow
dose range was used with both dicyclomine and chelerythrine
chloride. These dose ranges were chosen because, in pilot studies,
higher doses resulted in very few lever presses during a testing
session with this attention task. In this task, an increase in omissions (failure to press either lever on a trial) can be diﬃcult to
interpret, as it may reﬂect changes in multiple factors, including
motivation for reward and motoric functioning.
Previous experiments have found that PKC overactivity
can impair working memory (Birnbaum et al., 2004) and
that PKC inhibition can attenuate age-related working
memory deﬁcits in rats and monkeys (Brennan et al., 2009).
Thus, PKC inhibition that ‘normalizes’ relatively high levels
of PKC may be beneﬁcial for restoring some aspects of cognitive processing. The present results may be taken as evidence that abnormally low PKC activity may be associated
with attentional deﬁcits. Such a conclusion is consistent with
observations from patients with Alzheimer’s disease who
exhibit a disruption of PKC activity (Battaini et al., 1999;
Masliah et al., 1991; Wang et al., 1994) along with attentional
deﬁcits (Berardi et al., 2005; Parasuraman and Haxby, 1993).
Interestingly, PKC activation has been proposed as a treatment to restore some cognitive deﬁcits in patients with
Alzheimer’s disease (Sun and Alkon, 2010). Thus, abnormally
high or low levels of PKC activity may be detrimental to
cognitive processing, and restoring ‘normal’ levels of PKC
activity may be beneﬁcial for alleviating these cognitive
deﬁcits. In summary, the present ﬁndings support the hypothesis that muscarinic M1 receptors contribute to normal attentional processing and also support the idea that PKC is
involved in some, most likely bottom-up, aspects of performing attention-demanding tasks.
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